Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002644650 | SCV003528389 | uncertain significance | Inborn genetic diseases | 2022-06-09 | criteria provided, single submitter | clinical testing | The c.1262C>T (p.S421L) alteration is located in exon 9 (coding exon 8) of the NIPBL gene. This alteration results from a C to T substitution at nucleotide position 1262, causing the serine (S) at amino acid position 421 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005034832 | SCV005671236 | uncertain significance | Cornelia de Lange syndrome 1 | 2024-01-22 | criteria provided, single submitter | clinical testing |